JP2004509850A5 - - Google Patents

Download PDF

Info

Publication number
JP2004509850A5
JP2004509850A5 JP2002504958A JP2002504958A JP2004509850A5 JP 2004509850 A5 JP2004509850 A5 JP 2004509850A5 JP 2002504958 A JP2002504958 A JP 2002504958A JP 2002504958 A JP2002504958 A JP 2002504958A JP 2004509850 A5 JP2004509850 A5 JP 2004509850A5
Authority
JP
Japan
Prior art keywords
composition
effective amount
mammals
nitric oxide
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2002504958A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004509850A (ja
Filing date
Publication date
Priority claimed from US09/605,900 external-priority patent/US6601580B1/en
Application filed filed Critical
Publication of JP2004509850A publication Critical patent/JP2004509850A/ja
Publication of JP2004509850A5 publication Critical patent/JP2004509850A5/ja
Pending legal-status Critical Current

Links

JP2002504958A 2000-06-28 2001-06-22 一酸化窒素吸入による治療効果の促進方法 Pending JP2004509850A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/605,900 US6601580B1 (en) 2000-06-28 2000-06-28 Enhancing therapeutic effectiveness of nitric oxide inhalation
PCT/US2001/041102 WO2002000175A2 (en) 2000-06-28 2001-06-22 Enhancing therapeutic effectiveness of nitric oxide inhalation

Publications (2)

Publication Number Publication Date
JP2004509850A JP2004509850A (ja) 2004-04-02
JP2004509850A5 true JP2004509850A5 (enExample) 2008-07-31

Family

ID=24425654

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002504958A Pending JP2004509850A (ja) 2000-06-28 2001-06-22 一酸化窒素吸入による治療効果の促進方法

Country Status (10)

Country Link
US (2) US6601580B1 (enExample)
EP (1) EP1301076A4 (enExample)
JP (1) JP2004509850A (enExample)
KR (1) KR100849103B1 (enExample)
CN (1) CN100488497C (enExample)
AU (2) AU7362201A (enExample)
CA (1) CA2414409A1 (enExample)
IL (1) IL153702A0 (enExample)
MX (1) MXPA03000182A (enExample)
WO (1) WO2002000175A2 (enExample)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6656452B1 (en) 1997-10-21 2003-12-02 The General Hospital Corporation Use of inhaled NO as anti-inflammatory agent
US20070086954A1 (en) * 1998-11-23 2007-04-19 Miller Christopher C Method and apparatus for treatment of respiratory infections by nitric oxide inhalation
CA2254645A1 (en) * 1998-11-23 2000-05-23 Pulmonox Medical Corporation Method and apparatus for treatment of respiratory infections by nitric oxide inhalation
US7516742B2 (en) * 1999-11-24 2009-04-14 Cardinal Health 207, Inc. Method and apparatus for delivery of inhaled nitric oxide to spontaneous-breathing and mechanically-ventilated patients with intermittent dosing
US7122018B2 (en) * 2000-12-26 2006-10-17 Sensormedics Corporation Device and method for treatment of wounds with nitric oxide
US7335181B2 (en) * 2000-12-26 2008-02-26 Pulmonox Technologies Corporation Nitric oxide decontamination of the upper respiratory tract
US6432077B1 (en) * 2000-12-26 2002-08-13 Sensormedics Corporation Device and method for treatment of surface infections with nitric oxide
GB0125222D0 (en) * 2001-10-19 2001-12-12 Barts & London Nhs Trust Composition for the treatment of microbial infections
GB0125357D0 (en) * 2001-10-22 2001-12-12 Univ Brighton Improvements relating to catalytic antioxidants
AU2002352982B2 (en) * 2001-11-29 2008-03-06 Sound Pharmaceuticals Incorporated Methods and compositions for ameliorating the undesirable effects of chemotherapy
ES2497716T3 (es) * 2002-01-04 2014-09-23 Sound Pharmaceuticals Incorporated Composiciones para utilizar en métodos destinados a tratar la pérdida auditiva
CA2490392A1 (en) * 2002-06-21 2003-12-31 University Of Pittsburgh Of The Commonwealth System Of Higher Education Pharmaceutical use of nitric oxide, heme oxygenase-1 and products of heme degradation
US7531133B2 (en) * 2002-09-10 2009-05-12 Pulmonox Technologies Corporation Use of nitric oxide gas in an extracorporeal circuitry to treat blood plasma
US9138707B2 (en) 2002-12-10 2015-09-22 Sy Kimball Portable, nitric oxide generator
SE0300971D0 (sv) * 2003-04-03 2003-04-03 Aga Ab Nitric oxide in treatment of inflammation
AU2004255268B2 (en) 2003-07-09 2010-04-01 Loma Linda University Use of nitrite salts for the treatment of cardiovascular conditions
WO2005077005A2 (en) * 2004-02-04 2005-08-25 The General Hospital Corporation Enhancing the effectiveness of an inhaled therapeutic gas
US8518457B2 (en) * 2004-05-11 2013-08-27 Pulmonox Technologies Corporation Use of inhaled gaseous nitric oxide as a mucolytic agent or expectorant
AU2005244078A1 (en) * 2004-05-11 2005-11-24 Pulmonox Technologies Corporation Intermittent dosing of nitric oxide gas
US7362274B1 (en) * 2004-07-09 2008-04-22 Huan-Cheng Lien Coupled feed-in butterfly shaped left/right hand circularly polarized microstrip antenna
US20070154570A1 (en) * 2004-09-29 2007-07-05 Miller Christopher C Use of nitric oxide in the treatment and disinfection of biofilms
WO2006096759A2 (en) * 2005-03-08 2006-09-14 Sound Pharmaceuticals Incorporated Methods and compositions for treating cancer
WO2006125123A2 (en) * 2005-05-19 2006-11-23 University Of Cincinnati Methods for treating bacterial respiratory tract infections in an individual using acidified nitrite
WO2007057763A2 (en) * 2005-11-18 2007-05-24 Pulmonox Technologies Corporation Nitric oxide as an anti-viral agent, vaccine and vaccine adjuvant
US8790715B2 (en) * 2006-02-16 2014-07-29 Ino Therapeutics Llc Method and apparatus for generating nitric oxide for medical use
WO2007136789A2 (en) * 2006-05-19 2007-11-29 Medimmune, Inc. Methods of preventing, treating or ameliorating enhanced respiratory disease via innate immune mechanisms
FR2902002B1 (fr) * 2006-06-12 2010-08-27 Lvmh Rech Composition cosmetique anti-radicaux libres
US8079998B2 (en) * 2006-10-20 2011-12-20 Pulmonox Technologies Corporation Methods and devices for the delivery of therapeutic gases including nitric oxide
CL2007003193A1 (es) * 2006-11-07 2008-07-04 Gen Hospital Corp Metodo para evitar o reducir la vasoconstriccion a continuacion de la administracion de un portador de oxigeno vasoactivo, que comprende oxido nitrico gaseoso y otro agente activo; composicion farmaceutica que comprende un inhibidor de fosfodiesteras
US20080193566A1 (en) * 2007-02-09 2008-08-14 Miller Christopher C Use of high dose concentrations of gaseous nitric oxide
US20110008258A1 (en) * 2007-11-12 2011-01-13 Samsara Medicin Ab Methods relating to breathing disorders
CA2710349A1 (en) * 2007-12-27 2009-07-09 Aires Pharmaceuticals, Inc. Aerosolized nitrite and nitric oxide -donating compounds and uses thereof
US8720436B2 (en) * 2008-01-31 2014-05-13 Genosys, Inc. Nitric oxide gel apparatus and method
US9649467B2 (en) 2008-01-31 2017-05-16 Syk Technologies, Llc Nitric oxide reactor and distributor apparatus and method
US8434475B2 (en) 2008-01-31 2013-05-07 Genosys, Inc. Nitric oxide reactor and distributor apparatus and method
US8501090B2 (en) * 2008-03-24 2013-08-06 Christian S. Minton Anti-microbial gas apparatus and method
CA2671029A1 (en) 2009-06-30 2010-12-30 James S. Baldassarre Methods of treating term and near-term neonates having hypoxic respiratory failure associated with clinical or echocardiographic evidence of pulmonary hypertension
JP5581500B2 (ja) 2010-03-10 2014-09-03 学校法人北里研究所 虚血再灌流障害軽減用治療剤および治療装置
US8685467B2 (en) 2010-08-03 2014-04-01 J. W. Randolph Miller Nitric oxide generation, dilution, and topical application apparatus and method
EP2691087A2 (en) 2011-03-31 2014-02-05 László Gábor Szabó Pharmaceutical composition containing no, process for the preparation and use thereof
JP6389125B2 (ja) 2011-11-07 2018-09-12 ザ ジェネラル ホスピタル コーポレイション 赤血球の処理法
US10517817B2 (en) 2013-05-09 2019-12-31 Syk Technologies, Llc Deep topical systemic nitric oxide therapy apparatus and method
EP2908137A1 (en) * 2014-02-14 2015-08-19 Institut Pasteur Methods for in vitro investigating mitochondrial replication dysfunction in a biological sample, kits and uses thereof, therapeutic methods against progeroid-like syndromes or symptomes and screening method for identifying particular protease inhibitor(s) and/or nitroso-redox stress scavenger compound(s)
JP2014141536A (ja) * 2014-05-16 2014-08-07 Kitasato Institute 虚血再灌流障害軽減用治療剤および治療装置
US10058542B1 (en) 2014-09-12 2018-08-28 Thioredoxin Systems Ab Composition comprising selenazol or thiazolone derivatives and silver and method of treatment therewith
US20170182088A1 (en) * 2015-12-28 2017-06-29 Geno Llc Method and apparatus for administering nitric oxide with supplemental drugs
WO2017132275A1 (en) 2016-01-27 2017-08-03 Syk Technologies, Llc Nitric oxide topical application apparatus and methods
NZ753749A (en) 2016-11-17 2025-10-31 Renovion Inc Treatment of respiratory tract diseases and infections with glutathione compositions
PT3710036T (pt) 2017-11-17 2025-01-22 Renovion Inc Composições de ácido ascórbico estáveis e métodos de utilização das mesmas
CN109169638A (zh) * 2018-11-12 2019-01-11 苏州瑞徕生物科技有限公司 一种细胞保存液及其用途
US12459820B2 (en) 2020-06-11 2025-11-04 J. W. Randolph Miller Stabilized and NO2-inhibited nitric oxide generating gels for inhaled nitric oxide therapy
AU2023205178B2 (en) 2022-01-04 2025-09-25 Renovion, Inc. Aqueous solution comprising a glutathione salt

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5570683A (en) 1990-12-05 1996-11-05 The General Hospital Corporation Methods and devices for treating pulmonary vasoconstriction and asthma
DE10299002I1 (de) 1990-12-05 2012-07-05 Gen Hospital Corp Verwendung von No zur Behandlung oder Praevention der Bronchokonstriktion
US5396882A (en) 1992-03-11 1995-03-14 The General Hospital Corporation Generation of nitric oxide from air for medical uses
AU6528494A (en) * 1993-04-06 1994-10-24 Brigham And Women's Hospital Nitric oxide combination therapy
US5427797A (en) 1993-04-06 1995-06-27 Brigham And Women's Hospital Systemic effects of nitric oxide inhalation
US5728705A (en) 1993-10-04 1998-03-17 The Trustees Of Columbia University In The City Of New York Method of inducing vasorelaxation to treat pulmonary hypertension
US6063407A (en) * 1995-02-16 2000-05-16 The General Hospital Corporation Treatment of vascular thrombosis and restenosis with inhaled nitric oxide
US5823180A (en) 1995-04-03 1998-10-20 The General Hospital Corporation Methods for treating pulmonary vasoconstriction and asthma
AU6031096A (en) * 1995-06-05 1996-12-24 Duke University Nitrosylated and nitrated superoxide oxidants and reductants
ATE331505T1 (de) 1996-04-05 2006-07-15 Gen Hospital Corp Behandlung einer hämoglobinstörung
GB9801398D0 (en) * 1998-01-22 1998-03-18 Anggard Erik E Chemical compounds
SE9903985D0 (sv) * 1999-11-03 1999-11-03 Aga Ab Use of nitric oxide
CA2393724A1 (en) * 1999-12-23 2001-06-28 Nitromed, Inc. Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use

Similar Documents

Publication Publication Date Title
JP2004509850A5 (enExample)
WO2002000175A3 (en) Enhancing therapeutic effectiveness of nitric oxide inhalation
CA2335900A1 (en) Aqueous compositions containing corticosteroids for nasal and pulmonary delivery
WO2008054454A3 (en) Nitrogen-containing heterocycle derivatives, pharmaceutical compositions, and methods of use thereof as antiviral agents
WO2001054679A3 (en) Transdermal composition containing an anesthetic and a vasodilator agent
ITMO20020297A1 (it) Inalatore per preparati monodose in capsule.
TR200101033T2 (tr) Akış direnci hafifletilmiş, aerosol halindeki aktif maddenin verilmesi
WO2005070052A3 (en) Use of photodynamic therapy to enhance treatment with immuno-modulating agents
WO2009150421A3 (en) Composition for the treatment of hair loss and baldness
WO2004037843A3 (en) Steroid compounds comprising superoxide dismutase mimic groups and nitric oxide donor groups, and their use in the preparation of medicaments
WO2007064658A3 (en) Safe and effective methods of administering therapeutic agents
ES2342935T3 (es) Composiciones para prevencion y tratamiento de sintomas de tipo resfriado y gripe que comprenden polimeros mucoadhesivos seleccionados.
WO2007011396A3 (en) Particles for treatment of pulmonary infection
MXPA04012728A (es) Deshidroepiandrosterona dihidratada y metodos para el tratamiento de asma o una enfermedad pulmonar obstructiva cronica utilizando composiciones de la misma.
UA83320C2 (ru) Таблетка для рассасывания, содержащая октенидин и предназначенная для лечения воспалительных заболеваний полости рта и глотки
WO2004024122A1 (en) Composition and method for moisturizing nasal tissue
WO2003097050A3 (en) A selective inos inhibitor and a pde inhibitor in combination for the treatment of respiratory diseases
NO20051463L (no) Inhaleringssammensetninger med hoy legemiddelandel
JP2004519511A (ja) 視神経組織変性疾患治療用のｇａｂａ受容体モジュレータ
WO2006033713A3 (en) Methods for ciprofloxacin inhalation
WO2007044700A3 (en) Protectant combinations for reducing toxicities
Akhtar et al. A comprehensive Review on Buccal Drug Delivery System
TR200402299T4 (tr) Alerjik hastalıkların tedavisi için anilin disülfit türevleri
WO2011093811A3 (en) Pharmaceutical preparations comprising formoterol and fluticasone
JP2008518017A (ja) 相乗的な多機能性組成物の製造方法及び使用方法